Tag Patrick D. Lyden

Intravenous Thrombolysis

Key Points Intravenous (IV) recombinant tissue plasminogen activator (t-PA), commercially known as alteplase, remains the most commonly used therapy that is effective and safe for acute ischemic stroke. Pivotal trials in the 1990s demonstrated the beneficial effect of t-PA; subsequent…